BioAtla

BioAtla is a San Diego-based biopharmaceutical company that develops novel therapeutics for cancer. Its proprietary Conditionally Active Biologics (CAB) platform yields antibodies or other biologics that can be activated or inactivated under defined physiological conditions, and its Comprehensive Integrated Antibody Optimization (CIAO!) platform supports development of monoclonal antibody and cell-based therapeutics. The company states that its technologies are protected by more than 700 issued patents and patent applications.

BioAtla is a San Diego-based biopharmaceutical company developing novel therapeutics for cancer. Its Conditionally Active Biologics (CAB) platform exploits the unique microenvironment of diseased tissue to more effectively target cancer, yielding antibodies or other biologics that can be activated or inactivated under defined physiological conditions. The company also uses its Comprehensive Integrated Antibody Optimization (CIAO!) platform to develop novel monoclonal antibody and cell-based therapeutics. BioAtla states that these and other proprietary technologies are protected by more than 700 issued patents and patent applications.

Developing novel therapeutics with improved therapeutic index that are safer and more effective for treating cancer.

1. 1Home - BioAtlabioatla.com
2. 2About Us - BioAtlabioatla.com
3. 3BioAtla Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Sharesprnewswire.com
4. 4BioAtla Announces Pricing of Initial Public Offeringprnewswire.com